TTK and hepatocellular carcinoma: Silencing of AC099850.3 inhibited HCC cell proliferation and migration and led to significant inhibition of PLK1, TTK, CDK1, and BULB1 cell cycle molecules and CD155 and PDL1 immune receptors (23).